• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    多

    多伦多西部医院

    Toronto Western Hospital,University Health Network
    EST. 1895
    5,662论文总数
    29万引用总数

    论文量&引用量时间轴

    机构学者

    论文(5663)

    年份
    起
    –
    止
    排序
    1Perioperative Cefazolin Prophylaxis in Patients with Β-Lactam Allergy: a Quality Improvement Project
    Tariq Esmail, Mark T. McIntyre,David T. Wong, Chantelle A. Nielson, Indira Gobin, Philip Lui, Natalia Lauzon,Timothy Jackson,Alon Vaisman

    We sought to determine if the rate of cefazolin use for antimicrobial prophylaxis could be increased in elective surgical patients with a reported β-lactam antibiotic allergy with the use of a simplified questionnaire and without of skin testing. We conducted a quality improvement intervention at University Health Network, Toronto, ON, Canada by adapting a novel allergy assessment tool, the Modified Allergy Clarification for Cefazolin Evidence-based Prescribing Tool (ModACCEPT), which uses history alone to determine the safety of using cefazolin among patients with a self-reported β-lactam antibiotic allergy (SRBA) in the absence of skin testing. Prior to this, we performed knowledge dissemination campaigns to the surgical divisions and anesthesiology to communicate the safety of this approach. We used an interrupted time series analysis to determine the impact of the intervention on the proportion of patients with SRBA receiving cefazolin perioperative prophylaxis. Historic electronic data determined the stable rate of cefazolin administration within the institution at 28

    2026Canadian Journal of Anesthesia/Journal canadien d'anesthésie(2026)引用:25
    引用
    AI阅读
    加入学术空间
    2Cognitive Impairment in Cerebral Venous Congestion: the Need for Improved Assessment Tools - a Literature Review.
    Ferdinand K Hui,Sherief Ghozy, Matthew Robert Amans,Waleed Brinjikji,Mohamad Abdalkader,Vivek Yedavalli, Abraham Sc Chyung, Vitor M Pereira,Stephanie Lenck,Adnan H Siddiqui,Argye E Hillis,Kyle M Fargen

    ObjectiveCognitive impairment is increasingly recognized in patients with cerebral venous congestion (CVC), yet the cognitive tools used are largely adapted from stroke and dementia research. This review examines current literature on cognitive function in CVC, including conditions such as cerebral venous sinus thrombosis (CVST), idiopathic intracranial hypertension (IIH), and dural arteriovenous fistulas (dAVFs). Special emphasis is placed on the limitations of common screening tools like the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE). Cognitive dysfunction-primarily affecting executive function, processing speed, and attention-is reported in up to 86% of CVC cases, yet only about 20% of studies use validated cognitive testing tools, most of which may lack sensitivity for CVC-specific deficits. Emerging techniques such as ocular motor testing and physiological markers show promise but require further validation. There is an urgent need for standardized, CVC-specific cognitive assessment protocols that reflect the unique pathophysiology of venous disorders. Future research should prioritize the development of targeted cognitive batteries and integrate objective physiological measures to enhance diagnostic accuracy.

    2026Journal of neurointerventional surgery(2026)引用:7
    引用
    AI阅读
    加入学术空间
    3ASRA Pain Medicine Narrative Review and Expert Practice Recommendations for Gastric Point-of-care Ultrasound to Assess Aspiration Risk in Medically Complex Patients Undergoing Regional Anesthesia and Pain Procedures
    Stephen C Haskins,Yuriy S Bronshteyn,Leila Ledbetter,Cristian Arzola,Hari Kalagara, David Hardman, Oliver Panzer, Marissa M Weber, Eric R Heinz,Jan Boublik, Javier Cubillos, Nadia Hernandez,

    Gastric point-of-care ultrasound (POCUS) may offer clinical value in assessing aspiration risk among medically complex patients undergoing regional anesthesia and pain procedures. While the American Society of Anesthesiologists (ASA) preoperative fasting guidelines primarily apply to healthy individuals, medically complex populations often present with differing gastric emptying and aspiration risk. This narrative review, conducted by the American Society of Regional Anesthesia and Pain Medicine (ASRA-PM), adhered to PRISMA guidelines and was registered with PROSPERO. It focused on seven medically complex patient groups: those who are pregnant, obese, diabetic, have gastroesophageal reflux disease (GERD), are receiving emergency care, are enterally fed, or are taking GLP-1 receptor agonists (GLP-1RA). Study quality was assessed using the Mixed Methods Appraisal Tool (MMAT). Practice recommendations were developed using an iterative expert consensus process, with final recommendations based on evidence strength, clinical relevance, and expert agreement. Findings support the use of gastric POCUS in patients in active labor, those undergoing urgent cesarean sections, and those with diabetes. Conditional support is given for obesity, emergency care, enteral feeding, and GLP-1RA use. Routine use is not recommended in non-laboring pregnancies, elective cesarean delivery, or GERD. While gastric POCUS may aid with aspiration risk evaluation, its use should complement clinical judgment. Implementation may be limited by practical and training constraints, requiring individualized decision-making. These recommendations serve as a foundation for future research and potential clinical guideline development. PROSPERO registration number: CRD42023445927.

    2026Regional anesthesia and pain medicine(2026)引用:7
    引用
    AI阅读
    加入学术空间
    4Revisiting Parkinson's Disease Definition and Classification: Insights from Two Emerging Biological Frameworks.
    Nikolai Gil D. Reyes, Azalea Tenerife Pajo,Gerard Saranza, Günther U. Höglinger,Anthony E. Lang

    Parkinson's disease (PD) is increasingly recognized as a heterogeneous neurodegenerative entity with diverse clinical presentations, genetic contributors, and neuropathological features. Central to its pathogenesis is misfolded and aggregated α-synuclein, which collectively form Lewy pathology. Recent advances in biomarker and genetic research have enabled biologically grounded models of PD classification, diagnosis and staging. This review summarizes key principles, differences, and ongoing challenges of two emerging research frameworks: the SynNeurGe criteria and the Neuronal α-Synuclein Disease Integrated Staging System (NSD-ISS)-the former proposed a biologically based classification, while the latter proposed a more restrictive biological definition and staging schema. SynNeurGe incorporates synucleinopathy (S), neurodegeneration (N), genetic risk (G) and clinical status (C) to classify etiologic subtypes across the disease spectrum, emphasizing clinical heterogeneity and multifaceted underlying biological processes. In contrast, the NSD-ISS defines "neuronal α-synuclein disease" (NSD) based on specific molecular (S) and dopaminergic dysfunction (D) markers and a single genetic anchor (SNCA) (G), and maps disease progression across seven clinical stages. While both aim to improve early detection and to advance PD research, they differ in scope, operational definitions, implementation principles, and intended applications. Prevailing challenges include current limitations in mechanistic insights, biomarker standardization and accessibility, underrepresentation of genetic diversity, and ethical considerations around disease labeling and risk disclosure, particularly in asymptomatic cases. These frameworks represent a pivotal shift toward biologically based concepts of PD and related disorders, with future success contingent on continued refinement, validation, and equitable implementation.

    2026Journal of Neural Transmission(2026)引用:3
    引用
    AI阅读
    加入学术空间
    5Real-World Safety Profile of Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: a Multinational Multicenter Study.
    Bluyé DeMessie, Alireza Karandish,Muhammed Amir Essibayi, Hamza Adel Salim,Deepak Khatri, Neil Haranhalli, Amanda Baker,Richard Zampolin, Allan L. Brook,Seon-Kyu Lee,Nimer Adeeb,Dhairya A. Lakhani,

    Middle meningeal artery embolization (MMAE) has emerged as a treatment for chronic subdural hematoma (cSDH), but comprehensive real-world safety data remain limited. We performed a multicenter retrospective analysis of 1781 consecutive patients undergoing MMAE for cSDH (2019–2025). The primary outcome was any procedure-related complication within 30 days. Inverse probability of treatment weighting (IPTW) assessed the association between technical success and complications, adjusting for demographic, clinical, and procedural confounders. Mean age was 72.8 ± 12.4 years; 68.1

    2026Clinical Neuroradiology(2026)引用:2
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 5663 篇论文

    合作机构(100)

    多伦多大学合作论文 1,682
    多伦多大学健康网络合作论文 651
    卡尔加里大学合作论文 176
    McGill University合作论文 151
    华盛顿大学合作论文 133
    约翰斯·霍普金斯大学合作论文 124
    不列颠哥伦比亚大学合作论文 115
    伦敦安大略西部大学合作论文 114
    桑尼布洛克健康科学中心合作论文 109
    哥伦比亚大学合作论文 105

    机构统计